Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study

References

• Hoogduijn MJ. Are mesenchymal stromal cells immune cells? Arthritis Res Ther. 2015;17(1):88. doi:10.1186/s13075-015-0596-325880839
   PubMed Web of Science ®Google Scholar
• Sun Y, Deng W, Geng L, et al. Mesenchymal stem cells from patients with rheumatoid arthritis display impaired function in inhibiting Th17 cells. J Immunol Res. 2015;2015:284215. doi:10.1155/2015/28421525918734
   PubMed Web of Science ®Google Scholar
• Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum. 2003;48(4):917–926. doi:10.1002/art.1089712687533
   PubMed Web of Science ®Google Scholar
• Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood. 2001;98(8):2396–2402. doi:10.1182/blood.V98.8.239611588036
   PubMed Web of Science ®Google Scholar
• Alvaro-Gracia JM, Jover JA, Garcia-Vicuna R, et al. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Ann Rheum Dis. 2017;76(1):196–202. doi:10.1136/annrheumdis-2015-20891827269294
   PubMed Web of Science ®Google Scholar
• Munir H, McGettrick HM. Mesenchymal stem cell therapy for autoimmune disease: risks and rewards. Stem Cells Dev. 2015;24(18):2091–2100. doi:10.1089/scd.2015.000826068030
   PubMed Web of Science ®Google Scholar
• Li Z, Jiang CM, An S, et al. Immunomodulatory properties of dental tissue-derived mesenchymal stem cells. Oral Dis. 2014;20(1):25–34. doi:10.1111/odi.1208623463961
   PubMed Web of Science ®Google Scholar
• Mattar P, Bieback K. Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells. Front Immunol. 2015;6:560.26579133
   PubMed Web of Science ®Google Scholar
• Wang L, Wang L, Cong X, et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(24):3192–3202. doi:10.1089/scd.2013.002323941289
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–324. doi:10.1002/(ISSN)1529-01313358796
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Le Blanc K, Dominici M, et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393–395. doi:10.1080/1465324050031923416236628
   PubMed Web of Science ®Google Scholar
• Wang L, Huang S, Dang Y, et al. Cord blood-derived cytokine-induced killer cellular therapy plus radiation therapy for esophageal cancer: a case report. Medicine (Baltimore). 2014;93(28):e340–e340. doi:10.1097/MD.000000000000034025526496
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet (London, England). 2007;370(9602):1861–1874. doi:10.1016/S0140-6736(07)60784-3
   PubMed Web of Science ®Google Scholar
• Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheum. 2016;68(1):1–26.
   PubMed Web of Science ®Google Scholar
• Anderson PJ. Tumor necrosis factor inhibitors: clinical implications of their different immunogenicity profiles. In: Seminars in arthritis and rheumatism; Elsevier; 2005:19–22.
   Google Scholar
• McCain M, Quinet R, Davis WJ. Etanercept and infliximab associated with cutaneous vasculitis. Rheumatology (Oxford). 2002;41(1):116–117. doi:10.1093/rheumatology/41.1.11611792895
   PubMed Web of Science ®Google Scholar
• Bongartz T, AJ S, MJ S, Buchan I, EL M, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006;295(19):2275–2285. doi:10.1001/jama.295.19.227516705109
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rey E, Gonzalez MA, Varela N, et al. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis. 2010;69(01):241–248.19124525
   PubMed Web of Science ®Google Scholar
• Chen FH, RS T. Mesenchymal stem cells in arthritic diseases. JAr Ther. 2008;10(5):223.
   Google Scholar
• Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol Mech Dis. 2011;6:457–478. doi:10.1146/annurev-pathol-011110-130230
   PubMed Web of Science ®Google Scholar
• Rosset P, Deschaseaux F, Layrolle P. Cell therapy for bone repair. Orthop Traumatol Surg Res. 2014;100(1 Suppl):S107–S112. doi:10.1016/j.otsr.2013.11.01024411717
   PubMed Web of Science ®Google Scholar
• Chen J, Chen H, Li P, et al. Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds. Biomaterials. 2011;32(21):4793–4805. doi:10.1016/j.biomaterials.2011.03.04121489619
   PubMed Web of Science ®Google Scholar
• Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum. 2007;56(4):1175–1186. doi:10.1002/(ISSN)1529-013117393437
   PubMed Web of Science ®Google Scholar
• Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;30(1):42–48. doi:10.1016/S0301-472X(01)00769-X11823036
   PubMed Web of Science ®Google Scholar
• Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy. 2003;5(6):485–489. doi:10.1080/1465324031000361114660044
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003;31(10):890–896. doi:10.1016/S0301-472X(03)00110-314550804
   PubMed Web of Science ®Google Scholar
• Gao F, Chiu SM, Motan DA, et al. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 2016;7:e2062. doi:10.1038/cddis.2015.32726794657
   PubMed Web of Science ®Google Scholar
• Sakuma R, Takahashi A, Nakano-Doi A, et al. Comparative characterization of ischemia-induced brain multipotent stem cells with mesenchymal stem cells: similarities and differences. Stem Cells Dev. 2018;27(19):1322–1338. doi:10.1089/scd.2018.007529999479
   PubMed Web of Science ®Google Scholar
• Guan LX, Guan H, Li HB, et al. Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes. Exp Ther Med. 2015;9(5):1623–1630. doi:10.3892/etm.2015.233926136869
   PubMed Web of Science ®Google Scholar
• Bunpetch V, Wu H, Zhang S, Ouyang H. From “bench to bedside”: current advancement on large-scale production of mesenchymal stem cells. Stem Cells Dev. 2017;26(22):1662–1673. doi:10.1089/scd.2017.010428934885
   PubMed Web of Science ®Google Scholar
• Hamidian Jahromi S, Estrada C, Li Y, Cheng E, Davies JE. Human umbilical cord perivascular cells and human bone marrow mesenchymal stromal cells transplanted intramuscularly respond to a distant source of inflammation. Stem Cells Dev. 2018;27(6):415–429. doi:10.1089/scd.2017.024829402203
   PubMed Web of Science ®Google Scholar